Leuprorelin acetate Prescribing at PHOENIX HEALTH GROUP
Sex hormones and hormone antagonists in malignant disease | Malignant Disease and Immunosuppression
Items (12m)
281
Total Quantity
281
NHS Cost
£48.1K
vs National Avg
+506.4%
PHOENIX HEALTH GROUP prescribed 281 items of Leuprorelin acetate over the last 12 months at a cost of £48,101 to the NHS. This is 506.4% above the national average prescribing rate. Leuprorelin acetate is classified under Sex hormones and hormone antagonists in malignant disease in the BNF.
Monthly Prescribing Trend
Jul 2026
29
Jul 2026
19
Jul 2026
14
Jul 2026
28
Jul 2026
22
Jul 2026
27
Jul 2026
31
Jul 2026
14
Jul 2026
31
Jul 2026
29
Jul 2026
15
Jul 2026
22
Prescribing Details
| Total Items | 281 |
|---|---|
| Total Quantity | 281 |
| Total NHS Cost | £48,101 |
| Presentations | 4 different forms |
| vs National Average | +506.4% |
Leuprorelin acetate Prescribing Comparison
| This practice | 281 items |
|---|---|
| National average per practice | 46 items |
| Difference | +506.4% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.